申请人:Hoffman-La Roche Inc.
公开号:US05134123A1
公开(公告)日:1992-07-28
The compounds of the formula ##STR1## wherein A, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as set forth above, are described. The compounds of formula I have an inhibitory activity on the natural enzyme renin and can accordingly be used in the form of pharmaceutical preparations for the control or prevention of high blood pressure and cardiac insufficiency.
式子为##STR1##的化合物,其中A,R.sup.1,R.sup.2,R.sup.3, R.sup.4,R.sup.5和R.sup.6如上所述,被描述。 公式I的化合物具有天然酶肾素的抑制活性,因此可以用于制备药物制剂,用于控制或预防高血压和心脏不全。